Clinical Trials

ADPKD=autosomal dominant polycystic kidney disease; anti-IL-5 mAb=a monoclonal antibody that targets interleukin-5 (IL-5); BLyS=B-lymphocyte stimulator; BVAS=Birmingham Vasculitis Activity Score;  CTD=connective tissue disease; EGPA=eosinophilic granulomatosis with polyangiitis; ESKD=end-stage kidney disease; EULAR=European League Against Rheumatism; FVC=forced vital capacity; ILD=interstitial lung disease; KDIGO=Kidney Disease Improving Global Outcomes;  LN=lupus nephritis; mL=milliliter; mg=milligram; OCS=oral corticosteroids; OLE=open label extension; SLE=systemic lupus erythematosus; SSc=systemic sclerosis